[Treatment of acute destructive pancreatitis with recombinant interleukin-2].

Twenty-nine patients with acute destructive pancreatitis received combined therapy including recombinant interleukin-2 (ronkoleukin). Treatment with this interleukin led to a decrease of hypercytokinemia, reduced rate of purulent -- septic complications and surgical operations because of these complications.